It is of note that other members of the ankyrin family, namely ANK1 and ANK3, have been shown to be overexpressed in multiple human cancers including breast cancer [35,36], while ANK2 overexpression has been shown in pancreatic cancer where it contributed to the malignant phenotype [37]. Here, ANK3 is linked to breast carcinoma.